MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1023/b:thro.0000024050.78728.35

Медицинская библиотека · Journal of thrombosis and thrombolysis · 2003

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Newby L Kristin, Bhapkar Manjushri V, White Harvey D, Moliterno David J, LaPointe Nancy M Allen, Kandzari David E, Verheugt Freek W A, Kramer Judith M, Armstrong Paul W, Califf Robert M, SYMPHONY and 2nd SYMPHONY investigators

Клиническое исследованиеСтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

While aspirin's secondary prevention benefit is clear, prior reports indicate that 19-83% of eligible patients may not use aspirin chronically.

METHODS

We investigated intolerance and bleeding while on aspirin and aspirin discontinuation using 5337 post-acute coronary syndrome patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days. Multivariable logistic regression models tested associations between baseline characteristics and aspirin discontinuation and bleeding.

RESULTS

Nearly 18% of patients discontinued study aspirin; 48% subsequently used open-label aspirin and 5% other antiplatelet or anticoagulant therapy. Black race, recurrent ischemia, hypertension, chronic obstructive pulmonary disease, lighter weight, shorter time to treatment and use of non-steroidal anti-inflammatory agents, diuretics, and digitalis were independently associated with early discontinuation. Early discontinuation was less likely in Eastern Europe, Latin America and Asia. Although major or minor bleeding was common (12.6%), only 1.0% of aspirin-treated patients were reported to discontinue due to bleeding. Gastrointestinal (10.5%) and puncture site (7.6%) were the most common bleeding locations. Bleeding risk was associated with lower estimated creatinine clearance, shorter time to treatment, smoking, Killip class >II, higher systolic blood pressure, and use of aspirin or heparin prior to starting study aspirin.

CONCLUSIONS

Despite early initiation and close follow-up, more than 9% of aspirin-treated patients discontinued therapy early and remained off treatment. Addressing the factors associated with both bleeding and discontinuation during chronic therapy is necessary to improve adherence to this inexpensive, life-saving therapy.

Для цитирования: Newby L Kristin, Bhapkar Manjushri V, White Harvey D, Moliterno David J, LaPointe Nancy M Allen, Kandzari David E, Verheugt Freek W A, Kramer Judith M, Armstrong Paul W, Califf Robert M, SYMPHONY and 2nd SYMPHONY investigators. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.. Journal of thrombosis and thrombolysis. 2003. DOI: 10.1023/b:thro.0000024050.78728.35.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.